Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Robert Williams, Jr. Sells 7,000,000 Shares

Posted by Brenda Bartman on Jun 6th, 2026

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) major shareholder Robert Williams, Jr. sold 7,000,000 shares of Aveanna Healthcare stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $6.24, for a total value of $43,680,000.00. Following the sale, the insider owned 252,899 shares of the company’s stock, valued at approximately $1,578,089.76. This represents a 96.51% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Aveanna Healthcare Trading Up 0.8%

Aveanna Healthcare stock opened at $6.68 on Friday. The stock has a market cap of $1.45 billion, a PE ratio of 5.66, a P/E/G ratio of 0.74 and a beta of 1.93. The stock has a 50-day moving average price of $6.79 and a 200 day moving average price of $7.72. Aveanna Healthcare Holdings Inc. has a 52 week low of $3.73 and a 52 week high of $10.32. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 5.35.

Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.13 by $0.05. The firm had revenue of $647.92 million during the quarter, compared to analysts’ expectations of $613.22 million. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The company’s quarterly revenue was up 15.9% on a year-over-year basis. Equities research analysts predict that Aveanna Healthcare Holdings Inc. will post 0.6 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

AVAH has been the subject of a number of recent research reports. Stephens upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $10.00 to $11.00 in a research report on Friday, May 15th. BMO Capital Markets dropped their price objective on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating for the company in a research report on Friday, March 20th. Royal Bank Of Canada upgraded Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price objective for the company in a research report on Wednesday. Raymond James Financial upgraded Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price objective for the company in a research report on Friday, March 20th. Finally, Barclays dropped their price objective on Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating for the company in a research report on Monday, May 18th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, Aveanna Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $10.50.

Read Our Latest Research Report on Aveanna Healthcare

Institutional Trading of Aveanna Healthcare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Segall Bryant & Hamill LLC grew its holdings in Aveanna Healthcare by 425.8% in the 1st quarter. Segall Bryant & Hamill LLC now owns 163,966 shares of the company’s stock valued at $1,056,000 after buying an additional 132,779 shares during the period. Bank of America Corp DE grew its holdings in Aveanna Healthcare by 64.2% in the 1st quarter. Bank of America Corp DE now owns 402,510 shares of the company’s stock valued at $2,592,000 after buying an additional 157,368 shares during the period. Smith Group Asset Management LLC grew its holdings in Aveanna Healthcare by 34.3% in the 1st quarter. Smith Group Asset Management LLC now owns 263,669 shares of the company’s stock valued at $1,698,000 after buying an additional 67,393 shares during the period. EverSource Wealth Advisors LLC grew its holdings in Aveanna Healthcare by 22.1% in the 1st quarter. EverSource Wealth Advisors LLC now owns 17,552 shares of the company’s stock valued at $113,000 after buying an additional 3,172 shares during the period. Finally, The Manufacturers Life Insurance Company grew its holdings in Aveanna Healthcare by 56.3% in the 1st quarter. The Manufacturers Life Insurance Company now owns 36,509 shares of the company’s stock valued at $235,000 after buying an additional 13,155 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

(Get Free Report)

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.